Ramírez FF, Espinosa RP, Luévano RRK, Rojo GI, Mellado AJ

Language: Spanish
References: 22
Page: 24-28
PDF size: 45.43 Kb.

ABSTRACT

Introduction. Bronchiolitis is the most frequent respiratory tract infection on children ‹ 2 years old, in the 80% of the cases the etiological agent is the human respiratory syncytial virus (RSV). Either in the winter or in the early springs its cosmopolitan distribution and epidemic course takes place. There are some controversies about which of the treatments are the best. Today, the best therapies are hydration and oxygen therapy. The hypertonic salt solution has been a therapy option. Objective. To evaluate if the use of nebulized hypertonic sodium is effective, since there is evidence of its effectiveness in previous studies. Material and methods. Patients from 2 to 24 months who were admitted in paediatrics as a matter of urgency, with diagnose of bronchiolitis. They were evaluated through the modified Respiratory Distress Assessment Index (RDAI), with 4 as maximum score and without treatment for cardiopulmonary disease. Two groups were made: Group 1, patients with salt solution of 0.9%; Group 2, hypertonic sodium of 3% in micronebulizations every 4 hrs. Results. There were 32 patients, being more males than females; 71% vs. 29%, the 93.7% was between 2 and 12 months old, 17 patients in the group of salt solution of 0.9% with an average RDAI score of 5.7. They needed 12.6 nebulizations to have a RDAI score of 0. In the group of hypertonic sodium were 15 patients, with an average score of 6.7, they needed about 5.1 micronebulizations in order to get a RDAI score of 0. Conclusions. Despite the small number of patients, the study was statistically significant. The use of hypertonic solution reduced as much the number of micronebulizations as the days of intrahospitality stay. As a result, the hypertonic solutions are effective for treating bronchiolitis with success.

REFERENCES

1. Velasco RA. Bronquiolitis. Rev Méd Univ Ver 2006.

2. Zamorano RJ. Metapneumovirus humano en bronquiolitis por virus respiratorio sincitial. Rev Chil Infectol 2007; 20(2): 137-8.

3. Morano J. Compendio de Pediatría. Buenos Aires: Editorial Atlante, SRL; 2001, p. 463-6.

4. García MFJ, Moreno PD. Bronquiolitis. Asociación Española de Pediatría 2004: 29-36 [en línea] [Consulta: 3 de enero 2007].

5. Carrada BT. Patofisiología y Patogenia de la Bronquiolitis Viral. Avances recientes y perspectivas. Rev INER 2002; 15(3): 172- 91 [en línea] [Consulta: 8 de enero 2007].

6. Wills PJ, Hall RL, Chan W, Cole PJ. Sodium chloride increases the ciliary transportability of cystic fibrosis and bronchiectasis sputum on the mucus-depleted bovine trachea. J Clin Invest 1997; 99: 9-13.

7. Sood N, Bennett WD, Zeman K, et al. Increasing concentration of inhaled saline with or without amiloride: Effect on mucn cociliary clearance in normal subjects. Am J Respir Crit Care Med 2003; 167: 158-63.

8. Giachetto G, De Martín A, Sosa M. Seguimiento de niños oxígeno dependientes con secuelas pulmonares debidas a probable infección viral: primera descripción nacional. Rev Méd Urug 2002; 18(2): 161-6 [en línea] [Consulta: 15 de enero 2007].

9. Piippo SE, Remes S, Kannisto S, Coronen K, Corp M. Early predictors for adults asthma and lung function abnormalities in infants hospitalized for bronchiolitis: a prospective 18 to 20 year follow up. Allerg Asth Proc 2006; 27(4): 341-9 [en línea] [Consulta 21 de diciembre 2006].

10. Moreno CV, Cruz OGA, Martínez JB, Ortiz MVM. Una visión actualizada de la bronquiolitis por inhalación de aerosoles. Rev Mex Pediat 2004; 71(6): 289-91 [en línea] [Consulta: 15 de enero 2007].

11. Kuzik BA. Nebulized hypertonic saline in the treatment of viral bronchiolitis in infants. J Pediatr 2007; 151: 266-70.

12. Tal G, Cesar K, Oron A, Houri S, Ballin A, Mandelberg A. Hypertonic saline/epinephrine treatment hospitalized infants with bronchiolitis reduces hospitalization stay: 2 years experience. Isr Med Assoc J 2006; 8: 169-73.

13. Mandelberg A, Tal G, Witzling M, Someck E, Houri S, Balin A, et al. Nebulized 3% hypertonic saline solution treatment in hospitalized infants with viral bronchiolitis. Chest 2003; 123: 481.

14. Michael SE. Nebulized 3% hypertonic saline solution treatment in ambulatory children with viral bronchiolitis decreases symptoms. Chest 2002; 122; 2015-20. DOI 10.1378/chest 122.6.2015.

15. Speranza AM, Orazi V, Manfredi L, De Sarasqueta P. Programa Nacional de Infecciones Respiratorias Agudas Bajas. Hospitalización abreviada: un modelo de atención basado en evidencias altamente efectivo para descender la mortalidad infantil. Arch Arg Ped 2005; 103(3): 282-7 [en línea] [Consulta: 25 de enero 2007].

16. Ferrari AM, Pirez MC, Ferreira A, Rubio I, Montano A, Lojo R, et al. Estrategia de atención de niños hospitalizados por infecciones respiratorias bajas. Rev Sal Púb 2002; 36(3): 292-300 [en línea] [Consulta 28 de enero 2007].

17. González CD, González PYE. Bronquiolitis aguda: bases para un protocolo racional. An Esp Ped 2001; 55(4): 355-64 [en línea] [28 de diciembre de 2006].

18. Diagnosis and Management of Bronchiolitis Subcommittee on Diagnosis and Management of Bronchiolitis. DOI: 10.1542/ peds. 2006-2223.

19. Protocolos del GVR. Bronquiolitis. P-GVR-4.

20. Mark LE. Acute bronchiolitis. Pediatr Clin N Am 2009; 56: 119-33.

21. Zhang L, et al. Nebulized hypertonic saline solution for acute bronchiolitis in infants (Review) Copyright © 2008 The Cochrane Collaboration. Published by JohnWiley & Sons, Ltd.

22. Wainwright C. Acute viral bronchiolitis in children, a very common condition with few therapeutic options. Ped Resp Rev 2010;11: 39-45.